06/24/2026
Proposed policy changes around medications for opioid use disorder are sparking concern among healthcare experts, who warn that reduced access could impact treatment outcomes for people battling addiction.
Federal actions and proposals have reignited debate over methadone and buprenorphine, worrying addiction experts and patient groups.